In times of health emergency, controls on health supplies, medicines and food, among other things, are intensified to prevent the circulation of adulterated medical items. According to the World Health Organization (WHO), 1 million people die
globally for counterfeit medicines; it then becomes fundamental, amid a global pandemic, the consumption of enabled products, with detailed origin and control. That’s why GS1, a leading organization in the development of standards and solutions
identifying products and services, such as the barcode, shares a number of recommendations when buying medicines and supplies
approved health care, emphasizing above all the importance of acquiring them in
distribution channels enabled (pharmacies).
In this sense it is important to identify that the products have:Trade name (name of marketing of the medicine).
Generic name (of the drug or medicinal specialty).
Concentration, presentation and formula (Concentration of the drug and its pharmaceutical form; description of the amount of tablets or ml that the container brings, specifying whether it is over-the-counter or prescription-based archived).
Lot, expiration date and storage conditions: The batch uniquely identifies a item on the ANMAT label and certificates of analysis. Expiration sets its expiration. Where required, specific storage conditions such as temperature, use of a refrigerator, etc. will be detailed.
Laboratory Data: complete data of the owner, processing and/or importer must be provided in addition to legal address, company name and authorization certificate number, among others.
Barcode and die: It is part of the container that is removed when the patient buys a drug with social work and is sent attached with the prescription to request the withdrawal. There the drug is identified with a GTIN (it is a barcode that is used commercially to uniquely identify a product) produced by GS1.
In turn, GS1 worked on the incorporation of the commonly referred to as “barcodes” to ensure the safety, traceability and visibility of inputs: “Two decades ago we incorporated the barcode in Argentina and with it the possibility of
ensure security in one of the most important problems that occur in the world
with drug counterfeiting. Just as this tool has been a before and after in the pharmaceutical industry, we work to continue to innovate and simplify processes,” said Alejandro Rodríguez, General Manager of GS1 Argentina.In our country, GS1 collaborates with programs such as REMEDIAR and agencies such as PAMI and ANMAT to identify, locate and follow up on authorized medicines, supplies and medical devices so that they reach each of the patients without problems.